• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度口咽念珠菌病患者体外氟康唑敏感性与临床结局的相关性

Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

作者信息

Arikan S, Akova M, Hayran M, Ozdemir O, Erman M, Gür D, Unal S

机构信息

Department of Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey.

出版信息

Clin Infect Dis. 1998 Apr;26(4):903-8. doi: 10.1086/513927.

DOI:10.1086/513927
PMID:9564473
Abstract

We investigated the correlation between in vitro susceptibility to fluconazole and clinical response in severely ill patients with oropharyngeal candidiasis treated with fluconazole. The study included 48 adult patients, of whom 23 were neutropenic (absolute neutrophil count, < 500/mm3). Forty-eight isolates (20 Candida albicans, 12 Candida krusei, 10 Candida kefyr, 3 Torulopsis glabrata, and 3 Candida tropicalis) were tested for susceptibility to fluconazole with use of the macrodilution method of the National Committee for Clinical Laboratory Standards. A strain was considered to be susceptible to fluconazole if the MIC was < or = 8 micrograms/mL and resistant if the value was > or = 64 micrograms/mL. All but one of the resistant strains were C. krusei isolates. Species of causative Candida, persistent neutropenia, and susceptibility to fluconazole were significant predictors of clinical response by univariate analysis. Logistic regression analysis indicated that the only significant factor was the species of Candida isolates, validating the recently recommended MIC breakpoint and the correlation between clinical outcome and in vitro antifungal susceptibility.

摘要

我们研究了氟康唑体外药敏性与接受氟康唑治疗的重症口咽念珠菌病患者临床反应之间的相关性。该研究纳入了48例成年患者,其中23例为中性粒细胞减少症患者(绝对中性粒细胞计数<500/mm³)。采用美国国家临床实验室标准委员会的常量稀释法,对48株分离菌株(20株白色念珠菌、12株克柔念珠菌、10株解脂念珠菌、3株光滑念珠菌和3株热带念珠菌)进行氟康唑药敏试验。若最低抑菌浓度(MIC)≤8微克/毫升,则认为该菌株对氟康唑敏感;若MIC值≥64微克/毫升,则认为该菌株耐药。除1株耐药菌株外,其余所有耐药菌株均为克柔念珠菌分离株。单因素分析显示,致病念珠菌的种类、持续性中性粒细胞减少症以及对氟康唑的敏感性是临床反应的重要预测因素。逻辑回归分析表明,唯一的显著因素是念珠菌分离株的种类,这证实了最近推荐的MIC界值以及临床结局与体外抗真菌药敏性之间的相关性。

相似文献

1
Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.重度口咽念珠菌病患者体外氟康唑敏感性与临床结局的相关性
Clin Infect Dis. 1998 Apr;26(4):903-8. doi: 10.1086/513927.
2
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.HIV感染患者口腔念珠菌病的体外氟康唑耐药性与临床结局的相关性
Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):30-7. doi: 10.1007/BF01586182.
3
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.患有口咽念珠菌病的伊朗艾滋病毒/艾滋病患者:念珠菌属的鉴定、患病率及抗真菌药敏性
Lett Appl Microbiol. 2018 Oct;67(4):392-399. doi: 10.1111/lam.13052. Epub 2018 Aug 16.
4
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
5
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.从中国南方一个感染HIV的队列中单次及随访时分离出的白色念珠菌克隆株的抗真菌药敏异质性。
J Oral Pathol Med. 2001 Jul;30(6):336-46. doi: 10.1034/j.1600-0714.2001.300603.x.
6
Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.HIV感染患者中由白色念珠菌和非白色念珠菌菌株引起的混合性口咽念珠菌病。
Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):446-52. doi: 10.1007/BF01691310.
7
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.一项多中心随机试验,评估泊沙康唑与氟康唑治疗HIV/AIDS患者口腔念珠菌病的疗效。
Clin Infect Dis. 2006 Apr 15;42(8):1179-86. doi: 10.1086/501457. Epub 2006 Mar 14.
8
Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.白色念珠菌所致口腔念珠菌病的人类免疫缺陷病毒感染患者分离株中氟康唑的药敏模式。
Clin Infect Dis. 1997 Feb;24(2):124-30. doi: 10.1093/clinids/24.2.124.
9
Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者中耐氟康唑念珠菌的口咽携带率
Clin Infect Dis. 1997 Oct;25(4):843-6. doi: 10.1086/515554.
10
The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.HIV患者口腔念珠菌病中非白色念珠菌的流行病学
Spec Care Dentist. 2000 Sep-Oct;20(5):178-81. doi: 10.1111/j.1754-4505.2000.tb00015.x.

引用本文的文献

1
Clinical utility of antifungal susceptibility testing.抗真菌药敏试验的临床应用
JAC Antimicrob Resist. 2022 Jun 28;4(3):dlac067. doi: 10.1093/jacamr/dlac067. eCollection 2022 Jun.
2
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.氟康唑药效学与念珠菌血症患者死亡率的关联。
Antimicrob Agents Chemother. 2008 Sep;52(9):3022-8. doi: 10.1128/AAC.00116-08. Epub 2008 Jun 30.
3
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
氟康唑与念珠菌的解释性折点再探讨:抗真菌药敏试验未来的蓝图。
Clin Microbiol Rev. 2006 Apr;19(2):435-47. doi: 10.1128/CMR.19.2.435-447.2006.
4
Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.氟康唑在合成阴道模拟培养基中对白色念珠菌的杀菌活性。
Antimicrob Agents Chemother. 2004 Jan;48(1):161-7. doi: 10.1128/AAC.48.1.161-167.2004.
5
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.在侵袭性念珠菌病小鼠模型中,定量测定白色念珠菌麦角固醇含量可改善体外抗真菌药敏试验结果与氟康唑治疗后体内疗效之间的相关性。
Antimicrob Agents Chemother. 2000 Aug;44(8):2081-5. doi: 10.1128/AAC.44.8.2081-2085.2000.